Ginlong Technologies Co Ltd
300763.SZ · Producer Manufacturing · Electrical Products · CN
3,994 employees · ginlong.com/us
About
Ginlong Technologies Co., Ltd. generates revenue by manufacturing string inverters for DC to AC power conversion and grid interaction, targeting distributed photovoltaic power generation systems. The company sells single-phase string inverters, three-phase string inverters, and other inverters, alongside inverter fast shut-offs, data collectors, distributed wind power system products, and photovoltaic inverter parts. Its primary customers are overseas markets, where the firm distributes its products to support renewable energy infrastructure. The company's product portfolio focuses on reducing carbon footprints through efficient energy conversion solutions. Ginlong Technologies' business model relies on exporting its inverters and related components to international clients in the renewable energy sector. The firm's main products, including single-phase and three-phase string inverters, are designed for distributed photovoltaic systems, which are increasingly adopted globally. By offering a comprehensive range of inverter-related products, Ginlong addresses the growing demand for grid-connected renewable energy systems in overseas markets. The company's revenue streams are directly tied to the production and sale of these specialized components for solar power installations.
Annual results
Reported figures, CNY · revenue up 6.3% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 7.0B | 743M | 10.7% | — |
| 2024 | 6.5B | 691M | 10.6% | — |
| 2023 | 6.1B | 779M | 12.8% | — |
| 2022 | 5.9B | 1.1B | 18.0% | — |
| 2021 | 3.3B | 473M | 14.3% | — |
Dividends per share
300763.SZ in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Ginlong Technologies Co Ltd are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.